Category Archives: Technology

For Immediate Release

Chicago, IL January 29, 2021 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA Corporation NVDA, Verizon Communications, Inc. VZ, AstraZeneca PLC AZN, Micron Technology, Inc. MU and Anthem, Inc. ANTM.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA, Verizon Communications and AstraZeneca. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can seeall oftoday'sresearch reports here >>>

NVIDIAshares have outperformed the Zacks General Semiconductor industry over the past year (+110.4% vs. +28.8%), as the company benefited from the coronavirus-induced work-from-home and learn-at-home wave. It is also benefiting from strong growth in GeForce desktop and notebook GPUs, which is boosting gaming revenues.

Moreover, a surge in Hyperscale demand remains a tailwind for the company's Data Center business. Expansion of NVIDIA GeForce NOW is expected to drive user base. Further, solid uptake of AI-based smart cockpit infotainment solutions is a boon.

Additionally, collaboration with Daimler-owned Mercedes-Benz is expected to further strengthen NVIDIA's presence in the autonomous vehicles and other automotive electronics space. However, management expects COVID-19 pandemic to negatively impact near-term revenues by $100 million. Moreover, the U.S.-China trade war remains a key concern.

(You canread the full research report on NVIDIA here >>>)

Shares ofVerizonhave lost -4.1% in the last six months against the Zacks Wireless National industry's gain of +5.9%. The Zacks analyst believes that adoption of unlimited data plans has resulted in reduction of wireless service revenues. Hefty expenses on promotion and lucrative discounts to attract customers, further hampers its profitability.

Story continues

Verizon reported relatively solid fourth-quarter results with the top and bottom line beating the respective Zacks Consensus Estimate driven by a disciplined network strategy and focused roadmap for technology leadership. It expects to witness solid 5G momentum backed by customer-centric business model and diligent execution of operational plans.

Verizon is aiming to augment its mid-band spectrum capacity to support the evolving customer behavior. The company has offered a bullish guidance based on the resilient earnings performance and projected trends. However, Verizon operates in an intensely competitive U.S. wireless market that strains margins.

(You canread the full research report on Verizon here >>>)

AstraZenecashares have gained +2% over the past three months against the Zacks Large Cap Pharmaceuticals industry's rise of +15.4%. The Zacks analyst believes that AstraZeneca's products like Nexium, Crestor and Seroquel are facing generic competition, which is hurting sales.

The diabetes franchise also faces stiff competition while pricing pressure is hurting sales in the respiratory unit. Nonetheless, AstraZeneca's cancer medicines Lynparza, Tagrisso and Imfinzi should keep driving revenues. Its pipeline is strong with several phase III data readouts lined up. Its COVID-19 vaccine candidate, AZD1222 has progressed at a rapid pace.

AstraZeneca has also engaged in external acquisitions and strategic collaborations to boost its pipeline while investing in geographic areas of high growth like China. Its shares have underperformed the industry in the past six months. The company has a mixed record of earnings surprises in recent quarters. Estimates have gone down slightly ahead of Q4 earnings release.

(You canread the full research report on AstraZeneca here >>>)

Other noteworthy reports we are featuring today includeMicron Technology and Anthem.

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot stocks we're targeting >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumedthat any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein andis subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportVerizon Communications Inc. (VZ) : Free Stock Analysis ReportMicron Technology, Inc. (MU) : Free Stock Analysis ReportNVIDIA Corporation (NVDA) : Free Stock Analysis ReportAstraZeneca PLC (AZN) : Free Stock Analysis ReportAnthem, Inc. (ANTM) : Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research

See the original post here:

The Zacks Analyst Blog Highlights: NVIDIA, Verizon, AstraZeneca, Micron Technology and Anthem - Yahoo Finance

New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Tissue Ablation Market Research Report by Technology, by Indication, by Type - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06018567/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Tissue Ablation Market is expected to grow from USD 15,706.23 Million in 2020 to USD 21,630.47 Million by the end of 2025.2. The Global Tissue Ablation Market is expected to grow from EUR 13,771.52 Million in 2020 to EUR 18,966.01 Million by the end of 2025.3. The Global Tissue Ablation Market is expected to grow from GBP 12,242.91 Million in 2020 to GBP 16,860.82 Million by the end of 2025.4. The Global Tissue Ablation Market is expected to grow from JPY 1,676,253.67 Million in 2020 to JPY 2,308,519.93 Million by the end of 2025.5. The Global Tissue Ablation Market is expected to grow from AUD 22,807.54 Million in 2020 to AUD 31,410.32 Million by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the Tissue Ablation to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the Tissue Ablation Market studied across Cryoablation, Electrical Ablation, Hydromechanical Ablation, Light/Laser Ablation, Microwave Ablation, Radiofrequency (RF) Ablation, and Ultrasound Ablation.

Based on Indication, the Tissue Ablation Market studied across Cardiology, Cosmetology, Gynecology, Oncology, Ophthalmology, and Urology.

Based on Type, the Tissue Ablation Market studied across Minimally Invasive Surgery and Open Surgery.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Tissue Ablation Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Tissue Ablation Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Tissue Ablation Market including Abbott Laboratories, Alcon Inc., Alpinion Medical System, Angiodynamics, Inc., Atricure, Inc., Biosense Webster Inc., Boston Scientific Corporation, C.R Bard Inc., Chongqing Haifu Medical Technology Co., Ltd., Conmed Corporation, EDAP TMS, Ethicon, Inc., Galil Medical, Inc., HealthTronics, Inc., HS Hospital Service S.P.A, IceCure, Johnson & Johnson, Medtronic PLC, Mermaid Medical, Misonix, Inc., NeuWave Medical, Inc., Olympus Corporation, Shanghai A&S Science Technology Development, Smith & Nephew Plc, SonaCare Medical LLC., St Jude Medical, Stryker Corporation, and Theraclion.

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Tissue Ablation Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Tissue Ablation Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tissue Ablation Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tissue Ablation Market?4. What is the competitive strategic window for opportunities in the Global Tissue Ablation Market?5. What are the technology trends and regulatory frameworks in the Global Tissue Ablation Market?6. What are the modes and strategic moves considered suitable for entering the Global Tissue Ablation Market?Read the full report: https://www.reportlinker.com/p06018567/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Visit link:

Tissue Ablation Market Research Report by Technology, by Indication, by Type - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire

The human impact of COVID-19 on cancer care was summed up by Dr Tristan Cope, Medical Director at the Aintree University Hospitals NHS Foundation Trust. Its devastating for the patient if theyve come into a hospital, expecting to have a potentially life-saving cancer operation and, that morning, are told it cant go ahead, he stated.

Dr Hopes words get to the crux of the issue facing cancer care teams across the UK. The first wave of the pandemic created a worrying backlog; Cancer Research UK estimated that 12,750 fewer cancer patients had had surgery, 6,000 fewer had received chemotherapy, and 2,800 fewer had had radiotherapy due to the postponement of routine NHS care.

These findings will only have been exacerbated by the current crisis. Cancer charity Action Radiotherapy recently stated that cancer services would need to be working at around 120% to clear the backlog over the next two years. But without any extra funding for new, smarter equipment, the problem could take until 2025 to clear. Professor Pat Price, Chair of Action Radiotherapy, said: The message to the government is that you have really got to invest now, just get on with it and put some money behind it and respond to these smart solutions that are available. One of these smart solutions is AI-based technology, which has an important role to play in making cancer treatment more effective and efficient.

It is important to note that many hospitals have been innovative in their approach to delivering cancer care during the pandemic. Many are using hypofractionation regimes to optimise the delivery of radiotherapy. Hypofractionation is a technique where patients are given a smaller number of radiation treatments at a higher dosage rate. By reducing the number of sessions and hospital visits, treatment is faster, while also minimising patient exposure to COVID.

However, more powerful doses require greater precision. This is where Artificial Intelligence (AI) has an important role to play.

AI technology can automate and improve the time-consuming and skill-intensive task of outlining organs at risk. This ensures that healthy tissue is not impacted by radiotherapy treatment, a critical process given the higher doses delivered under hypofractionation regimes

Discussing the impact of AI Autocontouring technology, Angela Rubio, former Chief Medical Dosimetrist at the University of New Mexico Cancer Centre stated that: Prior to using AI, contouring for a head and neck cancer patient would take about two hours to complete. With autocontouring it takes about 30 minutes. That is a 75% time-saving for each head and neck patient. Essentially the technology is saving us seven hours a week; almost a full working day.

The widespread use of AI autocontouring has the potential to deliver similar efficiencies across NHS cancer clinics. This would enable time-pressured healthcare teams to treat more patients and tackle the COVID backlog.

The potential of AI autocontouring to enhance cancer treatment has been recognised by the UK government. Secretary of State for Health Matt Hancock stated that: the NHS is committed to fast-tracking pioneering AI technologies to the front line, freeing up clinicians time and saving lives. As part of this commitment, the NHS recently announced a 140m AI in Health and Care Award programme. It was positive to note that one of the key awards focused on progressing AI-based medical imaging.

While the government and healthcare practitioners recognise the value of AI autocontouring in cancer care, getting these solutions into the hands of frontline staff presents a major challenge. NHS staff are stretched to the limit as they tackle COVID whilst trying to minimise the impact on cancer treatment.

Dr Rob Chuter, Principal Clinical Scientist at The Christie NHS Foundation Trust, states that additional support is needed to deliver AI technologies more widely. Adopting and implementing new technologies into NHS infrastructure is a complex task requiring both investment and training. Clinicians just do not have the time for this at the moment, they are too busy to step off the conveyor belt. We need more resources for training and development to integrate AI technologies into cancer care, he states.

In response to this challenge, some of the companies developing AI autocontouring solutions are launching NHS Accelerator Programmes. These are designed to fast-track access to this technology at this critical juncture. Accelerators can significantly reduce the time taken for AI autocontouring to be live in clinics as well as providing hands-on support to upskill clinicians.

As we have seen, investment in AI technology has an important role to play in supporting the NHS as it seeks to maintain cancer care services and tackle the COVID backlog. However, the adoption of technology into the cancer care workflow is also an important building block for the future of cancer treatment in the UK. All predictions indicate unprecedented future demand for cancer care; Cancer Research UK projects a 40% increase in cases by 2025. By embedding AI technology into cancer care now, the NHS can ensure that one of the legacies of COVID is a more efficient and effective treatment system for the future.

Editor's Recommended Articles

More here:

AI technology can help tackle the cancer care backlog - Open Access Government

New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Grow Light Market Research Report by Installation, by Technology, by Spectrum, by Watt, by Lighting Type, by Product, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06015746/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Grow Light Market is expected to grow from USD 1,807.55 Million in 2020 to USD 3,300.77 Million by the end of 2025.2. The Global Grow Light Market is expected to grow from EUR 1,584.90 Million in 2020 to EUR 2,894.18 Million by the end of 2025.3. The Global Grow Light Market is expected to grow from GBP 1,408.98 Million in 2020 to GBP 2,572.93 Million by the end of 2025.4. The Global Grow Light Market is expected to grow from JPY 192,912.17 Million in 2020 to JPY 352,276.41 Million by the end of 2025.5. The Global Grow Light Market is expected to grow from AUD 2,624.81 Million in 2020 to AUD 4,793.16 Million by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the Grow Light to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Installation, the Grow Light Market studied across New Installation and Retrofit.

Based on Technology, the Grow Light Market studied across Fluorescent Lighting, High-intensity Discharge, and LED.

Based on Spectrum, the Grow Light Market studied across Full-spectrum and Partial Spectrum.

Based on Watt, the Grow Light Market studied across <300 Watt and >300 Watt.

Based on Lighting Type, the Grow Light Market studied across Interlighting and Toplighting.

Based on Product, the Grow Light Market studied across Hardware and Software & Services.

Based on Application, the Grow Light Market studied across Greenhouse, Indoor Farming, Turf and Landscaping, and Vertical Farming.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Grow Light Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Grow Light Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Grow Light Market including Aerofarms, Bowery Farming, Inc., California Lightworks, Crop One Holdings, Emium LLC, Epistar Corporation, Everlight Electronics Co. Ltd, Gavita International B.V., General Electric Company, Heliospectra AB, Hortilux Schreder B.V, Hydro Grow, Illumitex Inc., Indulux Technologies, Iwasaki Electric Co. Ltd, Kessil, LumiGrow, Inc., Metropolis Farms, Osram Gmbh, OSRAM Licht AG, Platinum LED Lights LLC, Royal Philips, Savant Systems Inc., Signify Holding, Sunlight Supply, Thrive Agritech, Valoya, Vividgro, and Zuzi Technology.

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Grow Light Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Grow Light Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Grow Light Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Grow Light Market?4. What is the competitive strategic window for opportunities in the Global Grow Light Market?5. What are the technology trends and regulatory frameworks in the Global Grow Light Market?6. What are the modes and strategic moves considered suitable for entering the Global Grow Light Market?Read the full report: https://www.reportlinker.com/p06015746/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read more from the original source:

Grow Light Market Research Report by Installation, by Technology, by Spectrum, by Watt, by Lighting Type, by Product, by Application - Global Forecast...

NAPLES, Fla., Jan. 29, 2021 /PRNewswire/ -- HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients and medical data, today announced that it will host the first annual Future of Healthcare Summit that will convene the top leaders in the $5 trillion healthcare industry at Arthrex's corporate campus that features a 30,000-SF fitness center and 200,000-SF Innovation Hotelin Naples, Florida from March 15-17th.

The summit is an invitation only event for healthcare providers. The event features world-class CEOs, innovators and industry experts who will come together to present a series of lectures on a wide range of healthcare topics and explore what can be done to both catalyze innovation and improve healthcare.

Dr. Michael Dent, HealthLynked's CEO has developed an agenda that focuses on genomics, functional medicine, anti-aging, stem cells, artificial intelligence, diagnostic advances, telemedicine, intellectual property, tissue regeneration, cancer treatments and medical devices.

The summit venue will be open to the public on Tuesday, March 16th, where a series of Ted Talk style lectures will cover the latest healthcare trends, technology, and treatments. This open forum will allow the public the opportunity to learn about the latest advances in healthcare and how they are being applied today and what to expect in future.

HealthLynked has confirmed a world-class slate of speakers including:

Attendees of the summit include doctors, hospital executives, academics, researchers, venture capitalists, pharmaceutical firms, policymakers, philanthropists, and future leaders. The seating for the summit will follow COVID-19 spacing guidelines and Arthrex campus facilities are equipped with Synexisair purification systems that kill airborne COVID-19 to add an additional layer of safety for the attendees.

For a look at the full agenda, as well as speaker bios, please visit the 2021 Healthcare Summitwebsite. For additional sponsorship opportunities please email [emailprotected].

Dr. Michael Dent, Chief Executive Officer of HealthLynked stated, "The next 15 years will bring a wave of medical breakthroughs in new therapies, medicines, medical devices and data analytics. We have achieved new milestones in gene editing, cancer immunotherapy and artificial intelligence. All of these advances will allow us to more effectively treat disease and find cures that have eluded us. Our goal is to provide an informative series of lectures to show the future of healthcare and create an environment for innovate thought leaders to turn ideas into actionable solutions."

About HealthLynked Corp.

HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries and personal health records, in one convenient online and secure location, free of charge. Participating healthcare providers can connect with their current and future patients through the system. Benefits to in-network providers include the ability to utilize the HealthLynked patent pending patient access hub "PAH" for patient analytics. Other benefits for preferred providers include HLYK marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling and to fill last minute cancelations using the Company's "real time appointment scheduling" all within its mobile application. Preferred providers pay a monthly fee to access these HealthLynked services. For additional information about HealthLynked Corp., please visit http://www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, and LinkedIn.

Forward Looking Statements

Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, including as a result of any acquisitions, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at http://www.sec.gov.

Contacts:

George O'Leary Chief Financial Officer [emailprotected] (800) 928-7144, ext. 103

Investor Relations Contacts:

Jim HockHanover International Inc.[emailprotected]760-564-7400

SOURCE HealthLynked Corp.

View post:

HealthLynked's The Future of Healthcare Summit Brings Healthcare Experts and Technology Innovators from Around the World to Naples, Florida -...

Intel RealSense ID is an on-device facial recognition solution from Intel. It combines an active depth-sensing camera technology with a specialized neural network to provide secure and user-aware facial authentication that can be used with several devices. Intel said that it has built RealSense ID with anti-spoofing systems that prevent attempts to unlock the device using images, videos, or masks. Intels RealSense tech has been in the news for a few years now, and the company has finally made it official.

Intel RealSense ID Solution F455 is a ready-to-use peripheral solution out-of-the-box. Intel also launched the F450 module in its RealSense ID lineup, which can be integrated and customized as per user needs. It is a small device comprising camera sensors, secure elements, an illuminator, a projector, and system-on-chip (SoC) to perform facial recognition. The SoC in this device performs the data processing and runs the neural networks to accurately match and recognize faces. The dual-camera setup is meant for authentication, while the IR illuminator and projector are used for indoor and outdoor operations. This tiny device also comes with a secure element that is meant to protect user data and privacy.

The neural network on the device is self-learning and adaptive making it more secure over time. According to Intel, the enrolment on this device is fairly straightforward, and the whole process of user registration takes less than a second. The device converts and encrypts the image data of the users into a system understandable format and does not store the actual photographs of the users. Moreover, only registered users will be authenticated using RealSense ID.

Intel also listed the datasheet (PDF download) of the RealSense ID and claims that it offers 99.76 percent true acceptance rates and uses the AES-256 encryption algorithm to store the authentication data. More information about the technicalities of Intel RealSense ID can be found here.

Intel RealSense ID Solution F455 is a small, compact device with the dimensions of 62 x 32.5 x 11 mm. The F450, meanwhile, sports the dimensions of 18 mm 50 mm 4.6 mm. It is suitable to use in both indoor and outdoor conditions and even in conditions with inadequate light. The device has a field of view of 56 78 and operates in a recommended range of 0.3-1 meter. The peripheral can be connected to other devices using USB-C and comes with an AUX port for SPI and GPIOs.

Passwords can no longer be trusted in the contemporary IT world. There have been several instances of cyberattacks and security breaches worldwide concerning stolen or misused credentials. Intel wants to patch this up using its facial recognition tech, which can be used as an additional layer or even the primary authentication source across several domains and platforms. The company also listed out that the probability of someone trying to trick or false-unlock its facial recognition system is one in a million.

RealSense ID is meant to provide smart access control in crucial industries such as banking, finance, health care, and IT. However, it can also be used in several other services such as transport, food, and several other industries that need simple identification or authentication.

The Intel RealSense ID is an open-source solution, and according to Intel, it has been developed this tech keeping developers in mind. The company is providing several code samples and documentation to demonstrate the process of integrating this authentication paradigm into the existing systems. Considering all these factors mentioned above, this new tech from intel can soon be seen in ATMs, kiosks, gate access controls at airports, railway stations, companies, and can also serve at POS systems. Considering the open-source nature of this technology, the applications can be endless, depending on how secure and accurate it proves to be in real-world use cases.

The RealSense ID peripheral F455 is currently up for pre-order for $99 whereas the F450 modules 10-pack is listed for $750. Both F455 and F450 are currently up for preorders on Intels website and shipping will begin in the week of March 1.

Intel is currently rolling out the RealSense ID for Windows OS and has stated that it will soon be launching it on Linux and Android operating systems leaving out Apples iOS and macOS. Moreover, the accuracy numbers of the RealSense ID are almost the same as Apples Face ID. This could be Intels message to Apple to take on the latters Face ID technology. While Apples Face ID is confined only to Apple devices, Intels RealSense ID is open-source and is cross-platform compatible. It is interesting that Intel came up with this after the long-lasting partnership with Apple ended when Apple ditched the intel processors to favor their in-house M1 line of chipsets to power the Macs. What are your opinions on this? Let us know in the comments.

Photo credits: Shutterstock (featured image) / Intel

Post Views: 23

Home Tech News Intel RealSense ID: In-depth look at this new facial recognition technology

The rest is here:

Intel RealSense ID: In-depth look at this new facial recognition technology - TechGenix

After a year of startling growth, the tech industry faces a more vexing 2021.

The pandemic helped bring the worlds tech giants such as Amazon.com Inc. and Microsoft Corp. to new heights in 2020. The shift to online shopping and remote working accelerated at a pace that would have been inconceivable without the coronavirus.

But there are signs the good times may end soon. Late last year, governments in the U.S., China and Europe separately began investigating whether Big Tech is too big. The scrutiny in Washington is expected to continue under a Biden administration, which also appears inclined to continue the Trump administrations export restrictions against Chinese companies that are reshuffling global supply chains.

While Big Tech faces perhaps its biggest challenge in years, some sectors can look forward to 2021. The world of electric vehicles may finally arrive. President-elect Joe Biden promises to make cybersecurity a priority. And Washington will start doling out financial incentives to help U.S. companies stay ahead of Chinese rivals.

Here are some of the tech industrys most important themes this year.

See the original post here:

The Five Biggest Issues for Technology Companies in 2021 - The Wall Street Journal

Technologies like artificial intelligence and human genome editing reveal and reflect even more about the complex and sometimes dangerous social architecture that lies beneath the scientific progress that we pursue, Dr. Alondra Nelson said today at a televised ceremony introducing President-elect Joe Bidens science team. On Friday, the Biden transition team appointed Nelson to the position of OSTP deputy director for science and society. Biden will be sworn in Wednesday to officially become the 46th president of the United States.

Nelson said in the ceremony that science is a social phenomenon and a reflection of people, their relationships, and their institutions. This means it really matters whos in the room when new technology like AI is developed, she said. This is also why for much of her career she has sought to understand the perspectives of people who are not typically included in the development of emerging technology. Connections between our scientific and social worlds have never been as urgent as they are today, she said, and theres never been a more important moment to situate scientific development in ethical values like equality, accountability, justice, and trustworthiness.

When we provide inputs to the algorithm; when we program the device; when we design, test, and research; we are making human choices, choices that bring our social world to bear in a new and powerful way, she said. As a Black woman researcher, I am keenly aware of those who are missing from these rooms. I believe we have a responsibility to work together to make sure that our science and technology reflects us, and when it does it reflects all of us, that it reflects who we truly are together. This too is a breakthrough. This too is an innovation that advances our lives.

Nelsons comments allude to trends of pervasive algorithmic bias and a well-documented lack of diversity among teams deploying artificial intelligence. Those trends appear to have converged when Google fired AI ethics co-lead Timnit Gebru last month. Algorithmic bias has been shown to disproportionately and negatively impact the lives of Black people in a number of ways, including use of facial recognition leading to false arrests, adverse health outcomes for millions, and unfair lending practices. A study published last month found that diversity on teams developing and deploying artificial intelligence is a key to reducing algorithmic bias.

Dr. Eric Lander will be nominated to serve as director of the OSTP and presidential science advisor. In remarks today, he called Americas greatest asset its unrivaled diversity and spoke of science and tech policy that creates new industries and jobs but also ensures benefits of progress are shared broadly among all Americans.

Scientific progress is about someone seeing something that no ones ever seen before because they bring a different lens, different experiences, different questions, different passions. No one can top America in that regard, but we have to ensure that everyone not only has a seat at the table, but a place at the lab bench, he said.

Biden also spoke at the ceremony, referring to the team he has assembled as one that will help restore Americas hope in the frontier of science while tackling advances in health care and challenges like climate change.

We have the most diverse population in the world thats in a democracy, and theres so much we can do. I cant tell you how excited weve been about doing this. We saved it for last. I know its not naming Department of Defense or attorney general, but I tell you what: You have more impact on what our children are going to face and our grandchildren are going to have opportunities to do than anyone, he said.

As part of todays announcement, Biden said the presidential science advisor will be a cabinet-level position for the first time in U.S. history. Vice President-elect Kamala Harris, whose mother worked as a scientist at UC Berkeley, also spoke. She concluded her remarks with an endorsement of funding for science, technology, engineering, and mathematics (STEM) education and an acknowledgment of Dr. Kizzmekia Corbett, a Black female scientist whose contributions helped create the Moderna COVID-19 vaccine.

The Biden-Harris campaign platform has also pledged to address some forms of algorithmic bias. While the Trump administration signed a few international agreements supporting trustworthy AI, the current presidents harsh immigration policy and bigoted rhetoric undercut any chance of leadership when it comes to addressing the ways algorithmic bias leads to discrimination or civil rights violations.

Earlier this week, members of the Trump administration introduced the AI Initiatives Office to guide a national AI strategy following the passage of the National Defense Authorization Act (NDAA). The AI Initiatives Office might be one of the only federal offices to depict a neural network and eagle in its seal.

Read more here:

Incoming White House science and technology leader on AI, diversity, and society - VentureBeat

With the passing of the year 2020, the government has missed the deadline for announcing its Science, Technology and Innovation Policy, 2020, which will be the fifth such policy since independence. It has, however, finalised a draft and put it up on the Department of Science and Technology website for public comments. The policy is broadly directional, lacks in specifics but still has several interesting ideas. Here are some:

A Science, Technology and Innovation (STI) Development Bank will be created to direct long-term investments in select strategic areas. For large-scale mission-mode programmes, rules of lending will be modified for an easier flow of finance.

A Strategic Technology Development Fund is to be set up to home-grow strategic technologies in areas such as nuclear science, space, cyber technology and biotechnology. The fund, managed by a Strategic Technology Development Board, will also provide finance to the private sector and higher education institutions for research with specific goals. The idea is to go beyond government departments to enhance innovation. A strategic export policy to enable private players to thrive in the international markets is on the cards.

Appropriate institutional mechanisms are to be created to dip into the untapped potential of the highly-skilled Indian scientific diaspora. There will be opportunities for them to return, or to contribute from wherever they are based. An engagement portal exclusively to bring together Indian scientists and technocrats worldwide and to engage with Indian researchers is being planned. The diaspora will participate in high-level consultations for key sectors.

The role of S&T in defining foreign policy priorities will be vitalized. Apart from S&T for diplomatic benefits, diplomacy for S&T development is to be promoted. Multilateral dialogues will be initiated with key partner countries on matters related to all aspects of technology and innovation, including issues around technology governance. The number of Indian S&T counsellors in various countries will be increased and will be empowered to create opportunities for greater participation of the Indian scientific community, both in India and abroad.

Read the rest here:

In brief: Science, Technology and Innovation Policy 2020 - BusinessLine

COLUMBUS, Ohio -- Across America, 2020 was a year of disruption. In a matter of days, how we live and work completely changed.

This pandemic also started what is perhaps the greatest relocation of talent since World War II, with Americans leaving large coastal hubs in search of a better work-life balance.

According to one survey of Silicon Valley workers by the workplace app Blind, 15% of Bay Area tech pros have left the region since COVID-19.

So where are they going? Many are choosing Ohio.

Recent data from LinkedIn, originally reported last month by Alex Kantrowitz for the newsletter Big Technology, show Cleveland was the nations second biggest net gainer of tech workers from April to October last year, compared with the prior year.

And just two weeks ago, U-Haul released its 2020 rankings of all 50 states based on migration growth. Ohio was ranked fourth. California was dead last at No. 50.

Why does attracting technology companies and tech professionals matter? High pay is one reason. In Texas, according to The Wall Street Journal, the Austin Chamber analyzed salary data from the Texas Workforce Commission and the U.S. Bureau of Labor Statistics over the past decade. The average annual salary in 2019 for a high-tech job in their region was about $125,000. For all industries, it was about $65,000.

While numbers and data are great, the real story is told by the people.

Chris Berry is president of OhioX, a nonprofit technology and innovation partnership dedicated to helping make Ohio a leading tech hub.

In 2020, Ohio welcomed Oskar Bruening as one of our newest residents. Bruening is the co-founder and chief technology officer of California-headquartered Peek, a travel technology company that helps people discover their next adventure. Bruening moved from the Bay area to Cleveland, where he now leads his global team. Peek has the backing of investors like former Google CEO Eric Schmidt and Jack Dorsey of Twitter and Square.

The story is also told by the co-founders of Clevelands MedPilot, a medical technology company which moved here from New York City in 2018. Two of the companys founders, Matt Buder Shapiro and Nathan Spoden, grew up in Northeast Ohio.

If youre building a health tech company, what better place to do it than in Cleveland? Their move has created a playbook for executives considering their own move.

Another boomerang is Carrie Murphy. For her first job after college, Murphy moved to New York City, where she spent years working at startups, recruiting for startups, and even spent some time at Goldman Sachs. About five years ago, Murphy moved back to Northeast Ohio so she could be closer to family. Murphy is now the vice president of community partnerships at Venture For America, a fellowship program for recent college graduates who want to become startup leaders and entrepreneurs. The organization places top graduates from universities across the country into startups in cities like Cleveland, Detroit, and Pittsburgh.

These three stories are not unique. Over the past year, Ive met and spoken with dozens of Ohioans who at one point lived and worked in places like New York City, Seattle, and San Francisco. Many are originally from Ohio, but not all. Some now work remotely for out-of-state companies and some moved here to join a local business. The one thing nearly all have in common is they work in technology or technology-focused careers.

As we move forward in a post-pandemic world, the cities and states that can keep, develop, and attract top talent will find themselves positioned for success. And while technology is great, its the people who make it all happen. Luckily for Ohio, we have the success stories that show the way.

Chris Berry is the president of OhioX, a statewide nonprofit technology and innovation partnership dedicated to helping make Ohio a leading tech hub. Its membership includes Fortune 500 companies, leading research institutions, technology-focused businesses, startups, and more. For more information, visit ohiox.org.

Have something to say about this topic?

* Send a letter to the editor, which will be considered for print publication.

* Email general questions, comments or corrections on this opinion column to Elizabeth Sullivan, director of opinion, at esullivan@cleveland.com.

View post:

Cleveland and Ohio suddenly contending in the race for technology talent: Chris Berry - cleveland.com